The Inducement Grant has been granted pursuant to the Company's 2023 Inducement Plan (the "Plan”). The Inducement Grant was ...

Molecular Partners AG (OTCMKTS:MLLCF – Get Free Report)’s stock price traded up 11.1% on Thursday . The company traded as high as $5.00 and last traded at $5.00. 700 shares changed hands during ...

Deals this year for MSD include a $1.9bn deal with fibroblast therapy company Mestag Therapeutics and a $1.3bn acquisition of ...

Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...

A round up of some stocks capturing attention this week, featuring INOVIQ, Tamboran Resources, Omni Bridgeway, Clarity Pharmaceuticals and Mesoblast.

In morning trade, the ASX healthcare stock is up 12% to $5.15. Investors have been bidding this clinical-stage ...

Researchers identified nicotinamide (NAM) and pyridoxine (PN) as safe, synergistic nutrients that restore muscle stem cell ...

Clarity Pharmaceuticals (ASX:CU6) has developed a novel radiopharmaceutical called "SAR-bisFAP", a product that could be used ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...